149 related articles for article (PubMed ID: 28716444)
1. Thiosemicarbazone derivatives, thiazolyl hydrazones, effectively inhibit leukemic tumor cell growth: Down-regulation of ribonucleotide reductase activity and synergism with arabinofuranosylcytosine.
Graser-Loescher G; Schoenhuber A; Ciglenec C; Eberl S; Krupitza G; Mader RM; Jadav SS; Jayaprakash V; Fritzer-Szekeres M; Szekeres T; Saiko P
Food Chem Toxicol; 2017 Oct; 108(Pt A):53-62. PubMed ID: 28716444
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine.
Saiko P; Steinmann MT; Schuster H; Graser G; Bressler S; Giessrigl B; Lackner A; Grusch M; Krupitza G; Bago-Horvath Z; Jaeger W; Fritzer-Szekeres M; Szekeres T
Phytomedicine; 2015 Jan; 22(1):213-22. PubMed ID: 25636891
[TBL] [Abstract][Full Text] [Related]
3. N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.
Saiko P; Ozsvar-Kozma M; Bernhaus A; Jaschke M; Graser G; Lackner A; Grusch M; Horvath Z; Madlener S; Krupitza G; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
Int J Oncol; 2007 Nov; 31(5):1261-6. PubMed ID: 17912455
[TBL] [Abstract][Full Text] [Related]
4. A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).
Saiko P; Graser G; Giessrigl B; Lackner A; Grusch M; Krupitza G; Basu A; Sinha BN; Jayaprakash V; Jaeger W; Fritzer-Szekeres M; Szekeres T
Biochem Pharmacol; 2011 Jan; 81(1):50-9. PubMed ID: 20849828
[TBL] [Abstract][Full Text] [Related]
5. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
[TBL] [Abstract][Full Text] [Related]
6. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
Horvath Z; Saiko P; Illmer C; Madlener S; Hoechtl T; Bauer W; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
Exp Hematol; 2005 Mar; 33(3):329-35. PubMed ID: 15730856
[TBL] [Abstract][Full Text] [Related]
7. The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent.
Sigmond J; Kamphuis JA; Laan AC; Hoebe EK; Bergman AM; Peters GJ
Biochem Pharmacol; 2007 May; 73(10):1548-57. PubMed ID: 17324380
[TBL] [Abstract][Full Text] [Related]
8. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
Fritzer-Szekeres M; Salamon A; Grusch M; Horvath Z; Höchtl T; Steinbrugger R; Jäger W; Krupitza G; Elford HL; Szekeres T
Biochem Pharmacol; 2002 Aug; 64(3):481-5. PubMed ID: 12147300
[TBL] [Abstract][Full Text] [Related]
9. Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.
Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Fritzer-Szekeres M; Szekeres T
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1541-4. PubMed ID: 15571294
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones.
Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
Biochem Pharmacol; 1994 Jul; 48(2):335-44. PubMed ID: 8053929
[TBL] [Abstract][Full Text] [Related]
12. New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity.
Zaltariov MF; Hammerstad M; Arabshahi HJ; Jovanović K; Richter KW; Cazacu M; Shova S; Balan M; Andersen NH; Radulović S; Reynisson J; Andersson KK; Arion VB
Inorg Chem; 2017 Mar; 56(6):3532-3549. PubMed ID: 28252952
[TBL] [Abstract][Full Text] [Related]
13. Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cells.
Höchtl T; Horvath Z; Bauer W; Karl D; Saiko P; Elford HL; Fritzer-Szekeres M; Szekeres T
Life Sci; 2004 Jan; 74(9):1071-80. PubMed ID: 14687648
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
Horvath Z; Murias M; Saiko P; Erker T; Handler N; Madlener S; Jaeger W; Grusch M; Fritzer-Szekeres M; Krupitza G; Szekeres T
Exp Hematol; 2006 Oct; 34(10):1377-84. PubMed ID: 16982330
[TBL] [Abstract][Full Text] [Related]
15. Potent ribonucleotide reductase inhibitors: Thiazole-containing thiosemicarbazone derivatives.
Ertas M; Sahin Z; Bulbul EF; Bender C; Biltekin SN; Berk B; Yurttas L; Nalbur AM; Celik H; Demirayak Ş
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900033. PubMed ID: 31475759
[TBL] [Abstract][Full Text] [Related]
16. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
17. A ribonucleotide reductase inhibitor with deoxyribonucleoside-reversible cytotoxicity.
Crona M; Codó P; Jonna VR; Hofer A; Fernandes AP; Tholander F
Mol Oncol; 2016 Nov; 10(9):1375-1386. PubMed ID: 27511871
[TBL] [Abstract][Full Text] [Related]
18. Substituted 2-acylpyridine-alpha-(N)-hetarylhydrazones as inhibitors of ribonucleotide reductase activity and L1210 cell growth.
Cory JG; Downes DL; Cory AH; Schaper KJ; Seydel JK
Anticancer Res; 1994; 14(3A):875-9. PubMed ID: 8074487
[TBL] [Abstract][Full Text] [Related]
19. Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein.
Kunos CA; Chiu SM; Pink J; Kinsella TJ
Radiat Res; 2009 Dec; 172(6):666-76. PubMed ID: 19929413
[TBL] [Abstract][Full Text] [Related]
20. Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells.
Madlener S; Illmer C; Horvath Z; Saiko P; Losert A; Herbacek I; Grusch M; Elford HL; Krupitza G; Bernhaus A; Fritzer-Szekeres M; Szekeres T
Cancer Lett; 2007 Jan; 245(1-2):156-62. PubMed ID: 16488533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
